Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 1/20 | 0.42 |
| ▸ | AKT1 | P31749 | 1/20 | 0.42 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 7/20 | 0.41 |
| ▸ | CA2 | P00918 | 7/20 | 0.41 |
| ▸ | CA9 | Q16790 | 7/20 | 0.41 |
| ▸ | CA12 | O43570 | 6/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12798042 | 0.92 | TSHR (0.48) | TSHRPAX8PRKCAAKT1PTK2 | |
| SCHEMBL16317615 | 0.84 | ALDH1A1 (0.41) | TSHRALDH1A1 | |
| SCHEMBL5578523 | 0.84 | TSHR (0.48) | TSHRPAX8PRKCAAKT1PTK2 | |
| SCHEMBL14199405 | 0.82 | ALDH1A1 (0.54) | PAX8PRKCAAKT1PTK2CA1 | |
| SCHEMBL16317613 | 0.82 | TSHR (0.41) | TSHRPAX8PRKCAAKT1PTK2 | |
| SCHEMBL12798041 | 0.81 | ALDH1A1 (0.49) | ALDH1A1KMT2A | |
| SCHEMBL23591488 | 0.77 | TSHR (0.56) | TSHRPAX8PRKCAAKT1PTK2 | |
| SCHEMBL14199413 | 0.76 | ALDH1A1 (0.52) | CA1CA2CA9ALDH1A1KMT2A | |
| SCHEMBL15083009 | 0.76 | TSHR (0.52) | TSHRPAX8PRKCAAKT1PTK2 | |
| SCHEMBL13290312 | 0.75 | L3MBTL1 (0.51) | TSHRPAX8CA1CA2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902158-B2 | Polysulfated glycosides and salts thereof | Ivax Drug Research Ltd. (HU) | 2011-03-08 | — | — | US | disclosed |
| US-20070281893-A1 | Polysulfated Glycosides And Salts Thereof | IVAX DRUG RESEARCH INSTITUTE LTD (HU) | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070281893-A1 | Polysulfated Glycosides And Salts Thereof | CFTR, AREG, STS | TSHR 4117/4885PAX8 4598/4885PRKCA 1961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.